Chronic myeloid leukaemia trials in Sweden
3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleSafety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Where
- Stockholm
- Age
- 1 year to 17 years
- People
- 70 worldwide
- Run by
- Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00 - Phase 1/2Taking peopleClinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Huddinge
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00 - Phase 2Taking peopleCombining Active and Passive DNA Hypomethylation
- Where
- Gothenburg, Lund, Stockholm, Uppsala
- Age
- 18 years and over
- People
- 196 worldwide
- Run by
- Kirsten Grønbæk
See details and how to joinNCT03999723